Background & Aims : To assess the effectiveness of CT during arteriography (CTA) in superselective transarterial chemoembolization (TACE) for invasive bladder cancer, and to report preliminary results of superselective TACE. Methods : Angiography was performed in 20 patients with invasive bladder cancer, using a combined CT-Angiography system. Of the 20 tumors, 19 were T3, one was T2. The vesical arteries were selected using a 3F microcatheter, and perfusion was confirmed using CTA. TACE was performed after administrating 40 to 100 mg of cisplatin, with and without gelatin sponge particles. The effects of TACE were assessed by surgery or a combination of cystoscopy and CT in 15 cases. Results : The vesical arteries were successfully selected in 18 of 20 patients. In 16 small tumors, the tumor stain was clearly depicted on CTA. In two large tumors, the vascular supply was identified as involving multiple arteries. One case showed complete remission, six showed partial remission, and eight showed no change. Complications included mild local pain around the perineum during TACE, and transient nausea in some patients. Conclusion : CTA may be useful in superselective TACE for invasive bladder cancer, and may contribute to effective treatment of bladder tumors. (Kitakanto Med J 2004 ; 54 : 81-86) 
Introduction
The treatment of bladder cancer varies according to the tumor staging.1,2 Patients with superficial bladder cancer are generally treated with transurethral resection followed by intra-vesical chemotherapy and have a relatively good prognosis. Patients with more invasive, but still localized tumors (T2, T3) are candidates for more aggressive local treatment, including partial or radical cystectomy, irradiation or a combination of surgery and systemic chemotherapy. Some patients receive intra-arterial chemotherapy, followed by radiation therapy or radical cystectomy. The rationale for intra-arterial infusion of chemotherapeutic agents is the increased dosage delivered to the tumor with reduced toxicity. Intra-arterial chemotherapy for invasive and locally advanced bladder cancer has been evaluated at many centers with various results. 3 (tumor without thickened wall) tumor. The tumor size ranged from 15mm to 60mm (mean 37mm). TACE was performed using the following procedures. A 4-french short sheath was inserted into the opposite side of bladder cancer. Aortography was performed using a pigtail catheter and pelvic arterial branching was observed. The internal iliac artery was selected with a cobra shaped catheter and anteroposterior and anterior medial oblique views were obtained. Anterior medial oblique views, usually 30°, showed branches of the internal iliac artery in most patients and the superior and inferior vesical arteries were also identified. A 3-french Microferret mimark) and a hydrophilic polymer-coated, 0.016-inch guide wire (GT wire, Terumo, Tokyo) were used in the superselection of vesical arteries.
A combined CT-Angiography system (AG-CT Miyabi, Siemens Medical Systems, Iselin, NJ) was used for CTA.11 Helical CT scans were obtained at the level extending from the sacroiliac articulation to the perineum by using a 5mm collimation and a table speed of 5mm (pitch of one). Iodine contrast material (iomeprol, lomeron 350, Eisai, Tokyo) was injected manually at the vesical artery. CT scanning was generally initiated 5 seconds after the injection of iodine contrast material. The bladder was filled with physiological saline through a urethral catheter during the scan.
When the tumor was detectable on CTA from the selected vessels, cisplatin was slowly infused, usually for about 30 minutes, using a mechanical injection pump. The cisplatin dosage was 40mg to 100mg, depending on the patient's weight, complaints, catheter tip location, and lumen size. In the case of large tumors supplied by two or more vesical arteries, cisplatin was separately administered. Finally, in 13 patients the vesical arteries, which had been infused with cisplatin, were embolized with a small amount of gelatin sponge particles. In five patients, TACE was performed two or three times. Tumors involving the bilateral bladder wall were approached through the bilateral femoral arteries.
The effects of TACE were assessed by surgery or a combination of cystoscopy and CT one month after TACE. Complete disappearance of bladder cancer was defined as complete remission, a decrease in tumor size exceeding 50 percent as partial remission, a decrease of less than 50 percent or an increase in tumor size exceeding 25 percent as no change, and an increase of more than 25 percent as progressive disease. The effects of TACE were evaluated by two radiologists (J. A., A.I.) and a urologist (M.I.), based on consensus.
Results
The vesical arteries were identified and successfully selected using a microcatheter in 18 of 20 patients. In one patient, the internal iliac arteries were completely occluded due to severe arteriosclerosis and in another, the vesical arteries were technically difficult to mi- CTA shows each region of the diffuse bladder cancer fed by multiple vesical arteries.
portion of the internal iliac artery. However, stains of small tumors (16/18) were not sufficiently visible on DSA, while CTA clearly revealed the tumor (Fig. 1A, B ). In several cases, the internal pudendal, uterine, vesicular, and vaginal arteries were difficult to distinguish from the vesical artery. In such cases, CTA precisely depicted the area of contrast enhancement through superselected arteries ( Fig. 2A, B) .
In two large tumors, vascular supply was demonstrated to involve multiple arteries based upon routine angiography and CTA facilitated the confirmation of the feeding area of each vesical artery (Fig. 3A, B, C) .
The inferior vesical artery was often found to feed the prostate and superior portion of the urethra on CTA (Fig. 4 ).
After these CTA findings had been obtained, appropriate TACE was performed in all 18 cases in whom vesical arteries were successfully selected ( Table  1) . The effects of TACE were assessed in 15 cases. Complete remission was observed in one case (Fig. 5 ), partial remission in six, and no change in eight. No cases showed progressive growth of the tumor.
No definitive effect of embolization using gelatin sponge particles was obtained. Four (22%) patients complained of mild local pain around the perineum during cisplatin injection but medication was not necessary. Seven (39%) patients experienced transient nausea after TACE. There were no severe complications, such as the dysfunction of the liver or kidneys and myelosuppression. 
